|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: DURAMED PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
Next: JANEX INTERNATIONAL INC, NT 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 4,000
<SECURITIES> 0
<RECEIVABLES> 14,032,775
<ALLOWANCES> 1,041,000
<INVENTORY> 28,391,089
<CURRENT-ASSETS> 46,393,573
<PP&E> 51,737,229
<DEPRECIATION> 22,320,281
<TOTAL-ASSETS> 78,264,288
<CURRENT-LIABILITIES> 28,882,733
<BONDS> 35,610,827
0
10,000,000
<COMMON> 262,647
<OTHER-SE> 1,601,076
<TOTAL-LIABILITY-AND-EQUITY> 78,264,288
<SALES> 20,667,278
<TOTAL-REVENUES> 20,667,278
<CGS> 11,498,514
<TOTAL-COSTS> 15,429,050
<OTHER-EXPENSES> 3,518,435
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,370,412
<INCOME-PRETAX> 342,531
<INCOME-TAX> 0
<INCOME-CONTINUING> 342,531
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 273,214
<EPS-BASIC> .01
<EPS-DILUTED> .01
</TABLE>
|
|